Intrinsic Value of S&P & Nasdaq Contact Us

Aerovate Therapeutics, Inc. AVTE NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
49/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$13.00
+385.1%

Aerovate Therapeutics, Inc. (AVTE) has 17 known insider and institutional holders on record. The largest holder is RA CAPITAL MANAGEMENT, L.P. with 7,893,678 shares. Other notable holders include Atlas Venture Fund XII, L.P. and NOYES TIMOTHY P.

AVTE Insider Ownership

Top Holder
RA CAPITAL MANAGEMENT, L.P.
7,893,678 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Ra Capital Management, L.p. 10 Percent Owner 7,893,678 2024-06-20
100%
2 Atlas Venture Fund Xii, L.p. Director 2,327,909 2022-07-19
29%
3 Noyes Timothy P Chief Executive Officer 200,000 2024-01-31
3%
4 Pigot Timothy Chief Commercial Officer 66,586 2024-01-24
1%
5 Verwijs Marinus Chief Technology Officer 66,586 2024-01-24
1%
6 Iwicki Mark T Director 12,500 2024-06-07
0%
7 Shah Rajeev M. Director 12,500 2022-06-22
0%
8 Dable Habib J Director 12,500 2024-06-07
0%
9 Grayzel David S. Director 12,500 2024-06-07
0%
10 Santel Donald J Director 12,500 2024-06-07
0%
11 Dorval Allison Director 12,500 2024-06-07
0%
12 Katabi Maha 10 Percent Owner 12,500 2024-06-07
0%
13 Resnick Joshua Director 12,500 2024-06-07
0%
14 Gillies Hunter Chief Medical Officer 5,602 2024-06-14
0%
15 Eldridge George A See Remarks 5,022 2024-06-14
0%
16 Niven Ralph Chief Scientific Officer 1,609 2024-02-07
0%
17 Dake Benjamin T See Remarks 1,507 2024-08-02
0%

No ownership data available for AVTE.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message